ASPS statement on Breast Implant Associated-Squamous Cell Carcinoma (BIA-SCC)September 8
On Sept. 8, 2022, the Food and Drug Administration (FDA) released a new safety communication about squamous cell carcinoma (SCC) and various lymphomas in the capsule around breast implants.
- Gluteal Fat Grafting: A joint safety statement August 18
- ASPS innovation partner MTI offers webinar series for start-ups and interested members August 18
- Remembering a pillar of plastic surgery, David Furnas, MD, 1931-2022 August 17
- Award highlights the educational importance of "The Innovators" August 15
At first, ASPS member Loren Schechter, MD, thought kids were setting off fireworks. Then he noticed the tree he was standing under was shaking. Then he smelled the gun powder. Read More